J. Laubenberger et al., PROTON MAGNETIC-RESONANCE SPECTROSCOPY OF THE BRAIN IN SYMPTOMATIC AND ASYMPTOMATIC PATIENTS WITH LIVER-CIRRHOSIS, Gastroenterology, 112(5), 1997, pp. 1610-1616
Background & Aims: Hepatic encephalopathy (HE) is associated with typi
cal changes of cerebral metabolite pattern observed by proton magnetic
resonance (MR) spectroscopy consisting of a depletion of myo-inositol
and an increase of glutamine. The aim of this study was to determine
whether abnormalities in brain metabolism in neurologically asymptomat
ic patients with liver cirrhosis can be detected by spectroscopy. Meth
ods: In a prospective study, 39 patients with liver cirrhosis were exa
mined clinically according to standardized neuropsychological tests to
define whether overt, subclinical, or no hepatic encephalopathy was p
resent. All patients underwent proton MR spectroscopy at short echo ti
mes. Results: Spectroscopy allowed for the diagnosis of subclinical HE
in 4 of 4 cases and of overt HE in 10 of 11 cases. In 24 cases of mer
e liver cirrhosis and normal neuropsychological testing, a typical met
abolic pattern with a depletion of myo-inositol and an increased gluta
mine peak were found. A good correlation between the glutamine signal
and the clinical grading was found. Conclusions: Proton MR spectroscop
y allows for the diagnosis of HE and subclinical HE, also shows the ty
pical pathological metabolite pattern in patients with cirrhotic liver
s without subclinical HE, and might be more sensitive than neuropsycho
logical testing. Glutamine could serve as a spectroscopic marker for t
he clinical state of the patients.